NCI funds cancer research centers for 2027–2029 to advance prevention, detection, diagnosis, and treatment through translational research reaching a human endpoint; a clinical trial is required.
The Joint NCI/SPORE/P20 Program supports SPORE and P20 awardees in expanding clinical trials to advance patient-centric translational cancer research without duplicating SPORE-funded work.
The NIH Specialized Center Grant (P50) funds multidisciplinary research centers with a unifying scientific theme, requiring collaborative projects, shared resources, and an administrative core.
NIH's limited competition supports expansion and sustainability of biomedical research centers at eligible institutions in states with historically low NIH funding; clinical trials are not allowed.
UNC Lineberger Innovation Pilot Research Awards Program: 2026 Pilot Awards supports faculty with new cancer research projects to advance innovation and stimulate applications for external funding.
This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.